More than a pen...
Product Innovation
- Comprehensive and highly accurate sensor technologies built into the NeuroMotor PenTM
- Short, simple test reports with clinically relevant information
- User interface to non-invasively record and analyse parameters of minute limb and hand motion and quantify fine motor skill, represented by ‘motion features’
- Motion features are translated into biomarkers to provide objective information about movement abnormalities which support diagnosis and monitoring of Parkinson's disease and other impairments
- Analytical engine with Decision Support System
- Time logged assessment, enabling to monitor changes over time
- Full audit trail of results
- Patented and CE marked as a medical device
- Manufacturing setup with ISO 13485 quality management system for medical devices
Product Benefits
For Neurology practices:
- Increasing certainty of differential diagnosis, especially Parkinson's versus Essential Tremor
- Monitoring motor symptoms conveniently with highest possible accuracy and automated record keeping
- Patient monitoring by non-specialist to reduce specialist time
- Reducing cost compared to DaTscan assessment
- Improving accuracy where there is insufficient access to skillful consultants
- Improving departmental efficiency
- Reducing delays in diagnosis and implementation of treatment
- Patients experiencing a simple, non-threatening test with easily interpretable results that can be shown
For primary care and community practices:
- Triaging use to increase referral accuracy and save on costs for approximately 50% referrals (UK)
- In non-neurological care settings to use as a screening tool for pre-symptomatic screening of apparently healthy individuals in groups at risk
Pharmaceutical industry:
- Ensuring subjects recruited for trials are correctly identified as PD or non-PD
- Supporting the evaluation of pharmaceutical interventions during trials
- Measuring the change in severity of the movement disorder throughout the trial
Manus Neurodynamica is revolutionising neuromotor health care management by using their patented technology and unique diagnostic algorithms to record validated biomarkers of neuromotor impairments and differentiate between movements, to radically improve patient diagnosis and disease management.
Data Security
Manus Neurodynamica has implemented best-in-class encryption & cloud security technology providing:
- Dedicated Microsoft Windows IoT with integrated Manus NMP app installation
- A secure and locked down tablet device dedicated to NMP
- Encryption and anonymisation of data on the tablet
- Secure Cloud infrastructure, storage and data transport
- Complex workflow implementation for software updates, licensing and remote device management
Manus Neurodynamica is a member of the Microsoft™ Partner program.
How the
NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
The NeuroMotor Pen™ offers an accurate and objective assessment of movement abnormalities to aid the differential diagnosis and clinical management of patients with neuromotor impairments,
as well as monitoring changes in symptoms in response to treatment.
The NeuroMotor Pen™ offers an accurate and objective
assessment of movement abnormalities to aid the differential diagnosis
and clinical management of patients with neuromotor impairments,
as well as monitoring changes in symptoms in response to treatment.
The NeuroMotor Pen™ offers an accurate and objective
assessment of movement abnormalities to aid the differential diagnosis
and clinical management of patients with neuromotor impairments,
as well as monitoring changes in symptoms in response to treatment.
How the
NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
Patients complete a set of standardized NeuroMotor™ Pen handwriting and drawing tasks
with the NeuroMotor™ Pen App on a high-end tablet PC. The tasks were developed to derive as much information about the subject’s neuromotor processing with relatively few tasks.
The Pen has a wireless connection with the tablet, from where the data is sent to the cloud application, where the NeuroMotor™ Pen algorithms analyse the minute limb
and hand motion to provide the results in the App.
SmartPoints™ cybersecurity to medical standards is applied on the tablet, as well as for the data in transit and on the cloud.
Patients complete a set of standardized NeuroMotor™ Pen handwriting and drawing tasks
with the NeuroMotor™ Pen App on a high-end tablet PC.
The tasks were developed to derive as much information about the subject’s
neuromotor processing with relatively few tasks.
The Pen has a wireless connection with the tablet, from where the data is sent to the
cloud application, where the NeuroMotor™ Pen algorithms analyse the minute limb
and hand motion to provide the results in the App.
SmartPoints™ cybersecurity to medical standards is applied on the tablet,
as well as for the data in transit and on the cloud.
Patients complete a set of standardized NeuroMotor™ Pen handwriting and drawing tasks
with the NeuroMotor™ Pen App on a high-end tablet PC. The tasks were developed to derive as much information
about the subject’s neuromotor processing with relatively few tasks.
The Pen has a wireless connection with the tablet, from where the data is sent to the
cloud application, where the NeuroMotor™ Pen algorithms analyse the minute limb
and hand motion to provide the results in the App.
SmartPoints™ cybersecurity to medical standards is applied on the tablet,
as well as for the data in transit and on the cloud.
How the
NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
The results of the NeuroMotor Pen™ motor skill tests are presented
as biomarkers with an easy to interpret numerical format
on the graphical user interface.
The results of the NeuroMotor Pen™ motor skill tests are presented
as biomarkers with an easy to interpret numerical format
on the graphical user interface.
The results of the NeuroMotor Pen™ motor skill tests are presented
as biomarkers with an easy to interpret numerical format
on the graphical user interface.
How the
NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
The NeuroMotor™ Pen with analytical software that calculate the biomarkers can non-invasively differentiate between Parkinson’s and other disease or signs normal ageing that may mimic
the symptoms of Parkinson’s disease.
In addition to scoring biomarkers, a second level of outcome presentation
allows to categorise the results in, for example, likelihood of Parkinson’s vs Essential Tremor or other disease classification.
The NeuroMotor™ Pen with analytical software that calculate the biomarkers can non-invasively
differentiate between Parkinson’s and other disease or signs normal ageing that may mimic
the symptoms of Parkinson’s disease.
In addition to scoring biomarkers, a second level of outcome presentation
allows to categorise the results in, for example, likelihood of Parkinson’s vs Essential Tremor
or other disease classification.
The NeuroMotor™ Pen with analytical software that calculates the biomarkers can non-invasively
differentiate between Parkinson’s and other disease or signs normal ageing that may mimic
the symptoms of Parkinson’s disease.
In addition to scoring biomarkers, a second level of outcome presentation
allows to categorise the results in, for example, likelihood of Parkinson’s vs Essential Tremor
or other disease classification.
How the
NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
How the NeuroMotor Pen™ works
Manus Neurodynamica provides a robust and secure
data-processing and analysis architecture including
a cloud-based facility to allow clinicians to store
the test data safely and anonymously.
Manus Neurodynamica provides a robust and secure
data-processing and analysis architecture including
a cloud-based facility to allow clinicians to store
the test data safely and anonymously.
Manus Neurodynamica provides a robust and secure
data-processing and analysis architecture including
a cloud-based facility to allow clinicians to store
the test data safely and anonymously.
Investors
Make a difference today
Our disruptive technology has the potential to be used across many applications such as screening, rehabilitation, drug development and medicine optimisation. We are keen to continue collaborating with interested researchers, clinicians and practitioners on our research in different areas of neuromotor disease, as well as investors for further development of our projects in the EU and US.
Collaborators
